Aberrant Circulating SNHG1 Serves as a Biomarker to Distinguish Acute Myocardial Infarction and Construction of a Risk Model for Secondary Heart Failure

J Cardiovasc Pharmacol. 2022 Sep 1;80(3):464-470. doi: 10.1097/FJC.0000000000001298.

Authors

Guanghu Yang¹, Xin Gai¹, Maozhi Han², Feng Gao³, Lujun Qiao¹, Yonggang Tian¹

Affiliations

¹ Intensive Care Unit, Shengli Oilfield Central Hospital, Dongying, China.
² Department of Pharmacy, the 80th Army Hospital, Weifang, China; and.
³ Applied Pharmacology Laboratory, Weifang Medical University, Weifang, China.

PMID: 35881900
DOI: 10.1097/FJC.0000000000001298

No abstract available

MeSH terms

Biomarkers
Heart Failure* / diagnosis
Humans
Myocardial Infarction* / diagnosis

Substances

Biomarkers